Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention
暂无分享,去创建一个
H. Miyata | Masaki Kodaira | K. Fukuda | S. Kohsaka | M. Sawano | T. Kuno | Y. Numasawa | Ikuko Ueda | Masahiro Suzuki | S. Noma | S. Ishikawa | K. Negishi | T. Katsuki | I. Ueda | Toshiomi Katsuki
[1] M. Liang,et al. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention , 2018, Angiology.
[2] S. Yuasa,et al. Characteristics and in-hospital outcomes in young patients presenting with acute coronary syndrome treated by percutaneous coronary intervention , 2018, Cardiovascular Intervention and Therapeutics.
[3] S. Yuasa,et al. Predictors of high cost after percutaneous coronary intervention: A review from Japanese multicenter registry overviewing the influence of procedural complications , 2017, American heart journal.
[4] J. Spertus,et al. Association of Variation in Contrast Volume With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention , 2017, JAMA cardiology.
[5] K. Wieczorowska-Tobis,et al. Assessment of renal function in geriatric palliative care patients – comparison of creatinine-based estimation equations , 2017, Clinical interventions in aging.
[6] H. Miyata,et al. Barriers Associated With Door-to-Balloon Delay in Contemporary Japanese Practice. , 2017, Circulation journal : official journal of the Japanese Circulation Society.
[7] T. Murohara,et al. Impact of nutritional assessment and body mass index on cardiovascular outcomes in patients with stable coronary artery disease. , 2017, International journal of cardiology.
[8] H. Miyata,et al. Impact of Institutional and Operator Volume on Short-Term Outcomes of Percutaneous Coronary Intervention: A Report From the Japanese Nationwide Registry. , 2017, JACC. Cardiovascular interventions.
[9] Sidney C. Smith,et al. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. , 2016, American heart journal.
[10] H. Miyata,et al. Effect of Smoking Status on Clinical Outcome and Efficacy of Clopidogrel in Acute Coronary Syndrome. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[11] H. Miyata,et al. Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan. , 2016, Journal of the American College of Cardiology.
[12] Y. Arbel,et al. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity , 2016, Journal of Nephrology.
[13] H. Miyata,et al. An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS). , 2015, American heart journal.
[14] H. Miyata,et al. Outcomes of Percutaneous Coronary Intervention Performed With or Without Preprocedural Dual Antiplatelet Therapy. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[15] Lichuan Yang,et al. Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention , 2015, Nephrology.
[16] H. Miyata,et al. Angiographic Lesion Complexity Score and In-Hospital Outcomes after Percutaneous Coronary Intervention , 2015, PloS one.
[17] H. Miyata,et al. Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry , 2015, PloS one.
[18] H. Miyata,et al. Location of the culprit coronary lesion and its association with delay in door-to-balloon time (from a multicenter registry of primary percutaneous coronary intervention). , 2015, The American journal of cardiology.
[19] H. Miyata,et al. Gender Differences in In-Hospital Clinical Outcomes after Percutaneous Coronary Interventions: An Insight from a Japanese Multicenter Registry , 2015, PloS one.
[20] Michael E. Matheny,et al. Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Registry Cath‐PCI Registry , 2014, Journal of the American Heart Association.
[21] E. Edelman,et al. Intravascular Ultrasound Guidance to Minimize the use of Iodine Contrast in Percutaneous Coronary Intervention: The MOZART Randomized Controlled Trial , 2014 .
[22] H. Gurm,et al. The Association between Contrast Dose and Renal Complications Post PCI across the Continuum of Procedural Estimated Risk , 2014, PloS one.
[23] H. Miyata,et al. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.
[24] H. Miyata,et al. Impact of Coronary Dominance on In-Hospital Outcomes after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome , 2013, PloS one.
[25] T. Uejima,et al. Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. , 2013, Journal of cardiology.
[26] A. Rosengren,et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. , 2013, European heart journal.
[27] H. Gurm,et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. , 2012, Journal of the American College of Cardiology.
[28] J. Wetzels,et al. Epidemiology of contrast material-induced nephropathy in the era of hydration. , 2012, Radiology.
[29] B. Afşar,et al. Which anthropometric parameter is best related with urinary albumin excretion and creatinine clearance in type 2 diabetes: body mass index, waist circumference, waist-to-hip ratio, or conicity index? , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[30] H. Gurm,et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. , 2011, Journal of the American College of Cardiology.
[31] Marco Valgimigli,et al. Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.
[32] Hani Jneid,et al. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in , 2011, Journal of the American College of Cardiology.
[33] J. Messenger,et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. , 2010, Journal of the American College of Cardiology.
[34] P. Damman,et al. Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes , 2009, Heart.
[35] Sunil V. Rao,et al. Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry , 2009, Circulation. Cardiovascular interventions.
[36] R. R. Wolfe,et al. The danger of weight loss in the elderly , 2008, The journal of nutrition, health & aging.
[37] P. McCullough,et al. Contrast-induced acute kidney injury. , 2018, Journal of the American College of Cardiology.
[38] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[39] Sidney C. Smith,et al. Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. , 2007, The American journal of cardiology.
[40] F. Veglia,et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.
[41] P. McCullough,et al. Epidemiology of contrast-induced nephropathy. , 2003, Reviews in cardiovascular medicine.
[42] Kirk N. Garratt,et al. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.
[43] N. Weissman,et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? , 2002, Journal of the American College of Cardiology.
[44] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .